Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
carboplatin 10 mg/ml infusionsvæske, opløsning, hætteglas a 45 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
carboplatin 10 mg/ml infusionsvæske, opløsning, hætteglas a 15 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cisplatin 1 mg/ml koncentrat til infusionsvæske, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cisplatin 1 mg/ml koncentrat til infusionsvæske, hætteglas a 50 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cisplatin 1 mg/ml koncentrat til infusionsvæske, hætteglas a 100 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cisplatin 500 µg/ml koncentrat til infusionsvæske, hætteglas a 20 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cisplatin 50 mg pulver til infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely dacarbazine (as dacarbazine citrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
mitoxantron 2 mg/ml koncentrat til infusionsvæske, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
mitoxantron 2 mg/ml koncentrat til infusionsvæske, hætteglas a 12,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
mitoxantron 2 mg/ml koncentrat til infusionsvæske, hætteglas a 15 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
crisantaspase 10.000 IE pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Pentostatin 10 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Fludarabine phosphate 50 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cladribin 1 mg/ml koncentrat til infusionsvæske, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
docetaxel 40 mg/ml koncentrat til infusionsvæske, hætteglas a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
docetaxel 40 mg/ml koncentrat til infusionsvæske, hætteglas a 2 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
irinotecanhydrochloridtrihydrat 20 mg/ml koncentrat til infusionsvæske, hætteglas a 2 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
irinotecanhydrochloridtrihydrat 20 mg/ml koncentrat til infusionsvæske, hætteglas a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Verteporfin 15 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
mesna 100 mg/ml injektionsvæske, opløsning, ampul a 4 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
mesna 100 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
azathioprin 50 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ciclosporin 50 mg/1 ml olieholdigt koncentrat til infusionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ciclosporin 250 mg/5 ml olieholdigt koncentrat til infusionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
tacrolimus 5 mg/ml koncentrat til infusionsvæske, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely molgramostim 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
molgramostim 300 µg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Molgramostim 400 microgram powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lenograstim 263 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lenograstim 105 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Amifostine 500 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Amifostine 375 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
humant interferon gamma-1b 200 µg/ml injektionsvæske, opløsning, hætteglas a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon alfa-2b 10 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon alfa-2b 5 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon alfa-2b 3 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon alfa-2b 1 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon alfa-2b 6 MIE/ml injektionsvæske, opløsning, hætteglas a 3 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/ml injektionsvæske, opløsning, hætteglas a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon beta-1b 8 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon alfa-2a 6 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon alfa-2a 9 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon alfa-2a 12 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon beta-1a 6 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon alfa-2b 15 MIE/1 ml fyldt pen |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon alfa-2b 25 MIE/1 ml fyldt pen |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon alfa-2b 50 MIE/1 ml fyldt pen |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon alfa-2b 10 MIE/ml injektionsvæske, opløsning, hætteglas a 2,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon beta-1a 12 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon beta-1a 24 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/0,6 ml injektionsvæske, opløsning, cylinderampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
peginterferon alfa-2b 50 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
peginterferon alfa-2b 80 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
peginterferon alfa-2b 100 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
peginterferon alfa-2b 150 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
peginterferon alfa-2b 120 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
daclizumab 25 mg/5 ml koncentrat til infusionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
fosfestroltetranatrium 60 mg/ml injektionsvæske, opløsning, ampul a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
gestronolhexanoat 100 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
medroxyprogesteronacetat 200 mg/ml injektionsvæske, suspension, hætteglas a 2,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
buserelin 1 mg/ml injektionsvæske, opløsning, hætteglas a 5,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
octreotid 50 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
octreotid 100 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
octreotid 500 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
octreotid 200 µg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
octreotid 10 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
octreotid 20 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
octreotid 30 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
leuprorelinacetat 3,75 mg pulver til injektionsvæske, rekonstitution, + diluent + sæt |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
leuprorelinacetat 11,25 mg pulver til injektionsvæske, opløsning, rekonstitution + diluent |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
triptorelin 4,2 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lanreotid 30 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
rituximab 10 mg/ml koncentrat til injektionsvæske, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
rituximab 10 mg/ml koncentrat til infusionsvæske, hætteglas a 50 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Trastuzumab 150 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
jernsorbitol (50 mg/ml ferrojern) injektionsvæske, opløsning, ampul a 2 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
jernhydroxidsukrosekompleks 100 mg/5 ml (Fe) infusionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
hydroxocobalamin 1 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cyanocobalamin 1 mg/1 ml injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, ampul a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, ampul a 2,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, hætteglas a 17,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, hætteglas a 35 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
folinsyre 7,5 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, hætteglas a 30 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
folinsyre 3 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
folinsyre 15 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
folinsyre 30 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
folinsyre 3 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
epoetin alfa 2000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
epoetin alfa 4000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,4 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|